Hoglund Brandon K, Carfagno Vincent, Olive M Foster, Leyrer-Jackson Jonna M
Department of Medical Education, School of Medicine, Creighton University, Phoenix, AZ, United States.
School of Medicine, Midwestern University, Glendale, AZ, United States.
Int Rev Neurobiol. 2023;168:367-413. doi: 10.1016/bs.irn.2022.10.004. Epub 2022 Nov 7.
Metabotropic glutamate (mGlu) receptors are G protein-coupled receptors that play pivotal roles in mediating the activity of neurons and other cell types within the brain, communication between cell types, synaptic plasticity, and gene expression. As such, these receptors play an important role in a number of cognitive processes. In this chapter, we discuss the role of mGlu receptors in various forms of cognition and their underlying physiology, with an emphasis on cognitive dysfunction. Specifically, we highlight evidence that links mGlu physiology to cognitive dysfunction across brain disorders including Parkinson's disease, Alzheimer's disease, Fragile X syndrome, post-traumatic stress disorder, and schizophrenia. We also provide recent evidence demonstrating that mGlu receptors may elicit neuroprotective effects in particular disease states. Lastly, we discuss how mGlu receptors can be targeted utilizing positive and negative allosteric modulators as well as subtype specific agonists and antagonist to restore cognitive function across these disorders.
代谢型谷氨酸(mGlu)受体是G蛋白偶联受体,在介导脑内神经元和其他细胞类型的活性、细胞类型之间的通讯、突触可塑性和基因表达中起关键作用。因此,这些受体在许多认知过程中发挥重要作用。在本章中,我们讨论mGlu受体在各种认知形式及其潜在生理学中的作用,重点是认知功能障碍。具体而言,我们强调了将mGlu生理学与包括帕金森病、阿尔茨海默病、脆性X综合征、创伤后应激障碍和精神分裂症在内的脑部疾病中的认知功能障碍联系起来的证据。我们还提供了最近的证据,证明mGlu受体在特定疾病状态下可能产生神经保护作用。最后,我们讨论了如何利用正性和负性变构调节剂以及亚型特异性激动剂和拮抗剂来靶向mGlu受体,以恢复这些疾病中的认知功能。